Review: Oncolytic virotherapy, updates and future directions. - Wikidata - awgldk - TriplyDB

Review: Oncolytic virotherapy, updates and future directions.

Review: Oncolytic virotherapy, updates and future directions.

http://www.wikidata.org/entity/Q47160989

about

A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.Cryo-EM Structure of Seneca Valley Virus Procapsid.Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.Pediatric Melanoma and Drug Development.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.White paper on microbial anti-cancer therapy and prevention Oncolytic virus and PD-1/PD-L1 blockade combination therapy Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice

P2860

Q41928232-9233DF3B-3880-423A-8CCA-35BE98BA3436 Q47132045-894E779D-B00B-4445-B411-302D755A4477 Q47269211-6B11CB10-CDF5-44BC-92BA-32539D4243C0 Q47562626-878E02CB-2CE6-4502-8250-20A0EBA0EC4A Q50056861-26298D58-F950-44E2-B0FD-94F8E4634A0D Q50116255-536C8234-FDE9-4E88-A58D-6A33A2604E0B Q55257387-F886A95D-DED3-4194-A8DB-8E46CEA540BA Q55652233-70074D95-5DBC-4E24-8BCA-44DA4CFAE340 Q56898750-3C12A299-CADC-4684-8EE0-7F2834DF4A20 Q57174025-78738EAC-6494-413E-B91C-7552BBC2CB96 Q58565390-EFC23256-0720-4B6A-B70E-130AF7F423B8 Q58701885-4C38A823-A3D5-4380-BDFA-1A90F80657BE

P2860

Review: Oncolytic virotherapy, updates and future directions.

http://www.wikidata.org/entity/Q47160989

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Review: Oncolytic virotherapy, updates and future directions.

@en

Review: Oncolytic virotherapy, updates and future directions.

@nl

type

label

Review: Oncolytic virotherapy, updates and future directions.

@en

Review: Oncolytic virotherapy, updates and future directions.

@nl

prefLabel

Review: Oncolytic virotherapy, updates and future directions.

@en

Review: Oncolytic virotherapy, updates and future directions.

@nl

P1433

Q47160989-1854DD1C-3D46-4A95-8D7E-5324D8004D67

P1476

Q47160989-C6F54904-65B5-4B42-BB86-005B384FF787

P2093

Q47160989-69D95951-FD3B-4E4D-BAA3-C8BAF2643F6B

Q47160989-EA160B92-06D0-495E-8288-310D75BFA963

Q47160989-F62D117A-C57A-4AE0-B8A2-9590FD1F47B6

P2860

Q47160989-043E0821-2BE7-4EE2-882F-F485E9D27664

Q47160989-06C0FAE2-F7F2-4744-89BC-F63DBF2DFFD5

Q47160989-074C0978-E2FC-45A7-BCA8-595276681404

Q47160989-077C9E73-5042-4606-8D53-870C48F822F8

Q47160989-09A8776F-CE70-449E-9AAB-178CE712F454

Q47160989-0A21F6AE-1B96-4AA4-AAE0-04360AE65D04

Q47160989-0C583ECC-639C-4181-BCD3-6B1F35313F94

Q47160989-0C9DC61B-116E-4948-97C7-77B6B15DDC7A

Q47160989-0D7B8986-8D08-4F25-ADAC-EE888856F1BE

Q47160989-0F478F34-E9A0-4FE6-BA98-805352F71C68

P304

Q47160989-DE42C91C-59E7-4766-A668-C023DF0CCFB8

P31

Q47160989-1216132B-E215-4458-822B-139CEF1C034B

Q47160989-ae01074a-20ab-4920-86a9-6da694f9ba30

P356

Q47160989-DF04647A-97A6-4FC9-9DBE-D0192AB28BE9

P407

Q47160989-CBFAC4FD-62A5-4432-8CB1-8746C4E3AACB

P433

Q47160989-53038DC5-7906-4826-909B-0B8342146D34

P478

Q47160989-CC65F2C5-5DC3-4517-9B6E-8457FEDC4C0C

P577

Q47160989-D24C2596-C6CC-4758-B772-18A4B2C1823F

P698

Q47160989-12F5733F-7D25-44B5-A10B-F98FFA264FC7

P921

Q47160989-827DBAF3-2B68-4484-B476-E13A4A5003B9

P932

Q47160989-39223E8D-035C-46EE-9F84-2C6959DCBC42

P356

ONCOTARGET.18309

P1433

P1476

Review: Oncolytic virotherapy, updates and future directions.

@en

P2093

Christos Fountzilas

http://www.w3.org/2001/XMLSchema#string

Devalingam Mahalingam

http://www.w3.org/2001/XMLSchema#string

Sukeshi Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

Structure of Seneca Valley Virus-001: An Oncolytic Picornavirus Representing a New Genus

PD-1 and its ligands in tolerance and immunity

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

P304

102617-102639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18309

http://www.w3.org/2001/XMLSchema#string

P407

P433

60

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29254276

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5731986

http://www.w3.org/2001/XMLSchema#string